Brian Tambi, Director at Insys Therapeutics, Inc. (INSY), sold 4,900 shares at $60.00 ($294K) on 2015-05-26, disclosed to the SEC on 2015-05-27.
Open-market sale of $294k INSY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.00 | 1,800 | $108K | 36.7% |
| 2 | $60.09 | 3,100 | $186K | 63.3% |
| Total | $60.06 avg | 4,900 | $294K | 100% |
| Filing → |
| AKRX | SELL | 2017-08-09 | $345K | — | Filing → |
| AKRX | SELL | 2016-06-06 | $768K | — | Filing → |
| INSY | SELL | 2015-05-20 | $307K | — | Filing → |